Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study
Abstract
Citations
-
6 4
CrossRef
-
0
Web of Science
-
6 5
Scopus
Authors (18)
Cite as
Full text
full text is not available in portal
Details
- Category:
- Magazine publication
- Type:
- Magazine publication
- Published in:
-
Haematologica-The Hematology Journal
no. 102,
edition 4,
pages e156 - e159,
ISSN: 0390-6078 - ISSN:
- 0390-6078
- Publication year:
- 2017
- DOI:
- Digital Object Identifier (open in new tab) 10.3324/haematol.2016.151738
- Verified by:
- No verification
seen 72 times